Shell Asset Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$119K Sell
6,290
-8,642
-58% -$142K 0.01% 601
2025
Q2
$320K Sell
14,932
-3,042
-17% -$45.2K 0.01% 613
2025
Q1
$236K Sell
17,974
-536
-3% -$7.96K 0.01% 719
2024
Q4
$249K Hold
18,510
0.01% 751
2024
Q3
$393K Buy
+18,510
New +$333K 0.02% 581
2024
Q1
$306K Sell
19,365
-1,323
-6% -$18.1K 0.01% 674
2023
Q4
$189K Buy
20,688
+2,404
+13% +$16.6K 0.01% 878
2023
Q3
$102K Sell
18,284
-286
-2% -$2K ﹤0.01% 1084
2023
Q2
$150K Sell
18,570
-7,431
-29% -$54.8K 0.01% 1011
2023
Q1
$170K Sell
26,001
-91
-0.3% -$371 0.01% 984
2022
Q4
$64K Sell
26,092
-5,300
-17% -$16.6K ﹤0.01% 1237
2022
Q3
$157K Sell
31,392
-8,226
-21% -$48K 0.01% 1092
2022
Q2
$168K Buy
39,618
+24,275
+158% +$154K 0.01% 1159
2022
Q1
$153K Sell
15,343
-2,401
-14% -$17.9K ﹤0.01% 1219
2021
Q4
$139K Buy
+17,744
New +$223K ﹤0.01% 1285

Other funds holding OSCR

Shell Asset Management's OSCR Position: Q3 2025 in Review

Shell Asset Management reduced its Oscar Health (OSCR) stake by 58% in Q3 2025, selling an estimated $142K and leaving 6,290 shares worth $119K. The position accounts for 0.01% of the portfolio, ranked #601.

Shell Asset Management first reported a position in OSCR in Q4 2021 and has held it in 15 quarters since. The position peaked at $393K in Q3 2024. 343 funds tracked by Wall St. Rank hold OSCR as of Q3 2025.

  • Shell Asset Management held 6,290 shares of Oscar Health worth $119K as of Q3 2025.
  • Shell Asset Management sold 8,642 Oscar Health shares in Q3 2025, an estimated $142K.
  • Oscar Health made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #601 holding.
  • Shell Asset Management first reported a position in Oscar Health in Q4 2021 and has held it in 15 quarters since.
  • Shell Asset Management's Oscar Health position peaked at $393K in Q3 2024.
  • 343 funds tracked by Wall St. Rank held Oscar Health as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.